deltatrials
Completed PHASE3 INTERVENTIONAL NCT00003057

Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer

Randomized Trial of High-Dose Versus Conventional Dose Octreotide Acetate Versus Loperamide in the Treatment of Chemotherpay-Related Diarrhea in Patients With Colorectal Cancer

Sponsor: Cancer and Leukemia Group B

Updated 9 times since 2017 Last updated: Jun 14, 2023 Started: Mar 26, 1997 Primary completion: May 31, 2000
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Colorectal Cancer and Diarrhea and is currently completed. Cancer and Leukemia Group B leads this study, which shows 9 recorded versions since 1997 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Dec 2020 · 30 months · monthly snapshotCompleted~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshotCompleted~Jan 2021 – ~May 2023 · 28 months · monthly snapshotCompleted~May 2023 – ~Jul 2023 · 2 months · monthly snapshotCompleted~Jul 2023 – ~Jul 2024 · 12 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

9 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Jul 2023 — Jul 2024 [monthly]

    Completed PHASE3

  5. May 2023 — Jul 2023 [monthly]

    Completed PHASE3

Show 4 earlier versions
  1. Jan 2021 — May 2023 [monthly]

    Completed PHASE3

  2. Dec 2020 — Jan 2021 [monthly]

    Completed PHASE3

  3. Jun 2018 — Dec 2020 [monthly]

    Completed PHASE3

  4. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Mar 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cancer and Leukemia Group B
  • Eastern Cooperative Oncology Group
  • National Cancer Institute (NCI)
  • SWOG Cancer Research Network
Data source: Eastern Cooperative Oncology Group

For direct contact, visit the study record on ClinicalTrials.gov .